A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Current in vitro and animal tests for drug development are failing to emulate the systemic organ complexity of the human body and, therefore, to accurately predict drug toxicity. In this study, we present a multi-organ-chip capable of maintaining 3D tissues derived from cell lines, primary cells and biopsies of various human organs. We designed a multi-organ-chip with co-cultures of human artificial liver microtissues and skin biopsies, each a (1)/100,000 of the biomass of their original human organ counterparts, and have successfully proven its long-term performance. The system supports two different culture modes: i) tissue exposed to the fluid flow, or ii) tissue shielded from the underlying fluid flow by standard Transwell® cultures. Crosstalk between the two tissues was observed in 14-day co-cultures exposed to fluid flow. Applying the same culture mode, liver microtissues showed sensitivity at different molecular levels to the toxic substance troglitazone during a 6-day exposure. Finally, an astonishingly stable long-term performance of the Transwell®-based co-cultures could be observed over a 28-day period. This mode facilitates exposure of skin at the air-liquid interface. Thus, we provide here a potential new tool for systemic substance testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“More recently, developers are increasingly starting to produce their chips from thermoplastic materials, already used in other biotechnological applications: polystyrene (Lee et al., 2018), poly(methyl methacrylate) (Busek et al., 2021), polycarbonate (Wagner et al., 2013), and cyclic olefin copolymer. While being amenable for cheaper and more scalable fabrication processes as well as providing”
From Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility (2024) · cites this paper as Wagner et al., 2013
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The metabolic activity and function of cells fluctuate over time and similar observations have been reported in the literature [61,62].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
All About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,372
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
From 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Perfused multiwell plate for 3D liver tissue engineering
Domansky, K., Inman, W., Serdy, J., Dash, A., Lim, M. H. M., & Griffith, L. G. (2010) · Lab Chip · doi:10.1039/b913221j · Cited by 444
Zhang, C., Zhao, Z., Abdul Rahim, N. A., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b915147h · Cited by 340
Sung, J. H., Esch, M. B., Prot, J.-M., Long, C. J., Smith, A., Hickman, J. J., & Shuler, M. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41017j · Cited by 233
Lübberstedt, M., Müller-Vieira, U., Mayer, M., Biemel, K. M., Knöspel, F., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., & Zeilinger, K. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.04.013 · Cited by 227
Marx, U., Walles, H., Hoffmann, S., Lindner, G., Horland, R., Sonntag, F., Klotzbach, U., Sakharov, D., Tonevitsky, A., & Lauster, R. (2012) · Alternatives to Laboratory Animals · doi:10.1177/026119291204000504 · Cited by 177
Self-citationImura, Y., Sato, K., & Yoshimura, E. (2010) · Analytical Chemistry · doi:10.1021/ac100806x · Cited by 172
Research works printed but not linked: 1
- Ramachandran, 1999, Drug Metab. Dispos., 27, 1194
Cited by
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Maschmeyer, I., Lorenz, A. K., Schimek, K., Hasenberg, T., Ramme, A. P., Hübner, J., Lindner, M., Drewell, C., Bauer, S., Thomas, A., et al. (2015) · Lab on a Chip · doi:10.1039/c5lc00392j · Cited by 861
Self-citationFunctional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
3D printed microfluidics for biological applications
Ho, C. M. B., Ng, S. H., Li, K. H. H., & Yoon, Y.-J. (2015) · Lab on a Chip · doi:10.1039/c5lc00685f · Cited by 704
Organ-on-a-chip: recent breakthroughs and future prospects
Wu, Q., Liu, J., Wang, X., Feng, L., Wu, J., Zhu, X., Wen, W., & Gong, X. (2020) · BioMedical Engineering OnLine · doi:10.1186/s12938-020-0752-0 · Cited by 701
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling
Skardal, A., Shupe, T., & Atala, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.003 · Cited by 512
Herland, A., Maoz, B. M., Das, D., Somayaji, M. R., Prantil-Baun, R., Novak, R., Cronce, M., Huffstater, T., Jeanty, S. S. F., Ingram, M., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0498-9 · Cited by 500
Microfluidic 3D cell culture: from tools to tissue models
van Duinen, V., Trietsch, S. J., Joore, J., Vulto, P., & Hankemeier, T. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.05.002 · Cited by 500
“For example, Atac ¸ et al. show a co-culture of hair follicles with skin tissue slices in a microfluidic Boyden chamber-like system (Figure 2c) [29,30].”
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487
A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle
Xiao, S., Coppeta, J. R., Rogers, H. B., Isenberg, B. C., Zhu, J., Olalekan, S. A., McKinnon, K. E., Dokic, D., Rashedi, A. S., Haisenleder, D. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14584 · Cited by 479
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442
Application of microfluidic chip technology in pharmaceutical analysis: A review
Cui, P., & Wang, S. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.12.001 · Cited by 390
Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis
Frey, O., Misun, P. M., Fluri, D. A., Hengstler, J. G., & Hierlemann, A. (2014) · Nature Communications · doi:10.1038/ncomms5250 · Cited by 387
Organ-on-a-chip platforms for studying drug delivery systems
Bhise, N. S., Ribas, J., Manoharan, V., Zhang, Y. S., Polini, A., Massa, S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.004 · Cited by 381
“Multiple biomimetic liver-on-a-chip platforms have been long established for drug toxicity testing [15,89,96,100].”
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
The use of skin models in drug development
Mathes, S. H., Ruffner, H., & Graf-Hausner, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.006 · Cited by 318
Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Marx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
“A first proof of concept milestone was reached in 2013 when a reproducible 28-day co-culture of human 3D liver and skin model equivalents and long-term repeated dose substance exposure could be established in a two-organ version of the MOC platform (Wagner et al., 2013).”
Self-citationIngber, D. E. (2020) · Advanced Science · doi:10.1002/advs.202002030 · Cited by 277
Evolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip
Azizipour, N., Avazpour, R., Rosenzweig, D. H., Sawan, M., & Ajji, A. (2020) · Micromachines · doi:10.3390/mi11060599 · Cited by 277
Recent advances in microfluidic technologies for cell-to-cell interaction studies
Rothbauer, M., Zirath, H., & Ertl, P. (2018) · Lab on a Chip · doi:10.1039/c7lc00815e · Cited by 277
Ataç, B., Wagner, I., Horland, R., Lauster, R., Marx, U., Tonevitsky, A. G., Azar, R. P., & Lindner, G. (2013) · Lab on a Chip · doi:10.1039/c3lc50227a · Cited by 272
Self-citationVernetti, L., Gough, A., Baetz, N., Blutt, S., Broughman, J. R., Brown, J. A., Foulke-Abel, J., Hasan, N., In, J., Kelly, E., et al. (2017) · Scientific Reports · doi:10.1038/srep42296 · Cited by 271
Bauer, S., Wennberg Huldt, C., Kanebratt, K. P., Durieux, I., Gunne, D., Andersson, S., Ewart, L., Haynes, W. G., Maschmeyer, I., Winter, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14815-w · Cited by 272
Self-citationFibroblast heterogeneity and its implications for engineering organotypic skin models in vitro
Sriram, G., Bigliardi, P. L., & Bigliardi-Qi, M. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2015.08.001 · Cited by 269
Pumpless microfluidic platform for drug testing on human skin equivalents
Abaci, H. E., Gledhill, K., Guo, Z., Christiano, A. M., & Shuler, M. L. (2015) · Lab on a Chip · doi:10.1039/c4lc00999a · Cited by 262
Recent Advances in Body-on-a-Chip Systems
Sung, J. H., Wang, Y. I., Narasimhan Sriram, N., Jackson, M., Long, C., Hickman, J. J., & Shuler, M. L. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05293 · Cited by 268
Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function
Sriram, G., Alberti, M., Dancik, Y., Wu, B., Wu, R., Feng, Z., Ramasamy, S., Bigliardi, P. L., Bigliardi-Qi, M., & Wang, Z. (2018) · Materials Today · doi:10.1016/j.mattod.2017.11.002 · Cited by 256
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
“Co-culture of human models of healthy liver and skin (Wagner et al., 2013), liver and neuronal tissue (Materne et al., 2015), liver and pancreatic islets (Bauer et al., 2017), intestine, vasculature and liver (Maschmeyer et al., 2015a), and intestine, liver, skin and kidney (Maschmeyer et al.,…”
BackgroundResultInfluentialSelf-citationA microfluidically perfused three dimensional human liver model
Rennert, K., Steinborn, S., Gröger, M., Ungerböck, B., Jank, A.-M., Ehgartner, J., Nietzsche, S., Dinger, J., Kiehntopf, M., Funke, H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.043 · Cited by 255
Design and demonstration of a pumpless 14 compartment microphysiological system
Miller, P. G., & Shuler, M. L. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.25989 · Cited by 238
Microfluidics‐based 3D cell culture models: Utility in novel drug discovery and delivery research
Gupta, N., Liu, J. R., Patel, B., Solomon, D. E., Vaidya, B., & Gupta, V. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10013 · Cited by 236
Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
Deng, J., Wei, W., Chen, Z., Lin, B., Zhao, W., Luo, Y., & Zhang, X. (2019) · Micromachines · doi:10.3390/mi10100676 · Cited by 229
Organs-on-a-chip: a new tool for drug discovery
Polini, A., Prodanov, L., Bhise, N. S., Manoharan, V., Dokmeci, M. R., & Khademhosseini, A. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.886562 · Cited by 223
“Studies have been performed using immortal cell lines [26], primary human cells [27] and precision-cut tissue slices [28].”
BackgroundResultInfluentialMaschmeyer, I., Hasenberg, T., Jaenicke, A., Lindner, M., Lorenz, A. K., Zech, J., Garbe, L.-A., Sonntag, F., Hayden, P., Ayehunie, S., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.002 · Cited by 218
Self-citationState-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology
Alépée, N. (2014) · ALTEX · doi:10.14573/altex.1406111 · Cited by 217
Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening
Ahn, J., Ko, J., Lee, S., Yu, J., Kim, Y., & Jeon, N. L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.001 · Cited by 213
Long-term ex vivo maintenance of testis tissues producing fertile sperm in a microfluidic device
Komeya, M., Kimura, H., Nakamura, H., Yokonishi, T., Sato, T., Kojima, K., Hayashi, K., Katagiri, K., Yamanaka, H., Sanjo, H., et al. (2016) · Scientific Reports · doi:10.1038/srep21472 · Cited by 202
Rajan, S. A. P., Aleman, J., Wan, M., Pourhabibi Zarandi, N., Nzou, G., Murphy, S., Bishop, C. E., Sadri-Ardekani, H., Shupe, T., Atala, A., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.015 · Cited by 201
Microfluidic Organ‐on‐a‐Chip Technology for Advancement of Drug Development and Toxicology
Caplin, J. D., Granados, N. G., James, M. R., Montazami, R., & Hashemi, N. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500040 · Cited by 205
Sieber, S., Wirth, L., Cavak, N., Koenigsmark, M., Marx, U., Lauster, R., & Rosowski, M. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2507 · Cited by 199
“The herein described bone marrow model was built up on the multiorgan chip (MOC), a microfluidic device (Wagner et al., 2013).”
MethodSelf-citationAstashkina, A., & Grainger, D. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.008 · Cited by 195
A lung/liver-on-a-chip platform for acute and chronic toxicity studies
Bovard, D., Sandoz, A., Luettich, K., Frentzel, S., Iskandar, A., Marescotti, D., Trivedi, K., Guedj, E., Dutertre, Q., Peitsch, M. C., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc01029c · Cited by 195
Medium throughput breathing human primary cell alveolus-on-chip model
Stucki, J. D., Hobi, N., Galimov, A., Stucki, A. O., Schneider-Daum, N., Lehr, C.-M., Huwer, H., Frick, M., Funke-Chambour, M., Geiser, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32523-x · Cited by 190
3D printed nervous system on a chip
Johnson, B. N., Lancaster, K. Z., Hogue, I. B., Meng, F., Kong, Y. L., Enquist, L. W., & McAlpine, M. C. (2016) · Lab on a Chip · doi:10.1039/c5lc01270h · Cited by 191
Vernetti, L., Gough, A., Baetz, N., Blutt, S., Broughman, J. R., Brown, J. A., Foulke-Abel, J., Hasan, N., In, J., Kelly, E., et al. (2017) · Scientific Reports · doi:10.1038/srep44517 · Cited by 190
Satoh, T., Sugiura, S., Shin, K., Onuki-Nagasaki, R., Ishida, S., Kikuchi, K., Kakiki, M., & Kanamori, T. (2018) · Lab on a Chip · doi:10.1039/c7lc00952f · Cited by 181
Integrating biological vasculature into a multi-organ-chip microsystem
Schimek, K., Busek, M., Brincker, S., Groth, B., Hoffmann, S., Lauster, R., Lindner, G., Lorenz, A., Menzel, U., Sonntag, F., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50217a · Cited by 180
Self-citationOrgans-on-chips technologies – A guide from disease models to opportunities for drug development
Monteduro, A. G., Rizzato, S., Caragnano, G., Trapani, A., Giannelli, G., & Maruccio, G. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115271 · Cited by 175
Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device
Gori, M., Simonelli, M. C., Giannitelli, S. M., Businaro, L., Trombetta, M., & Rainer, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159729 · Cited by 176
Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow
Esch, M. B., Prot, J.-M., Wang, Y. I., Miller, P., Llamas-Vidales, J. R., Naughton, B. A., Applegate, D. R., & Shuler, M. L. (2015) · Lab on a Chip · doi:10.1039/c5lc00237k · Cited by 173
Advances in On-Chip Vascularization
Haase, K., & Kamm, R. D. (2017) · Regenerative Medicine · doi:10.2217/rme-2016-0152 · Cited by 173
Human-on-chip for therapy development and fundamental science
Luni, C., Serena, E., & Elvassore, N. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.08.015 · Cited by 168
Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges
Wang, Y. I., Carmona, C., Hickman, J. J., & Shuler, M. L. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701000 · Cited by 167
Bioprinted 3D vascularized tissue model for drug toxicity analysis
Massa, S., Sakr, M. A., Seo, J., Bandaru, P., Arneri, A., Bersini, S., Zare-Eelanjegh, E., Jalilian, E., Cha, B.-H., Antona, S., et al. (2017) · Biomicrofluidics · doi:10.1063/1.4994708 · Cited by 158
Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites
Theobald, J., Ghanem, A., Wallisch, P., Banaeiyan, A. A., Andrade-Navarro, M. A., Taškova, K., Haltmeier, M., Kurtz, A., Becker, H., Reuter, S., et al. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00417 · Cited by 166
Jin, Y., Kim, J., Lee, J. S., Min, S., Kim, S., Ahn, D., Kim, Y., & Cho, S. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801954 · Cited by 181
A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing
Dehne, E., Ramme, A. P., Terrasso, A. P., Serra, M., Alves, P. M., Brito, C., Sakharov, D. A., Tonevitsky, A., Lauster, R., & Marx, U. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.02.002 · Cited by 163
“Multi-organ chip manufacturing and culture Fabrication of the MOC was performed as described in Wagner et al. (2013).”
MethodSelf-citationMechanical Stimulation: A Crucial Element of Organ-on-Chip Models
Thompson, C. L., Fu, S., Heywood, H. K., Knight, M. M., & Thorpe, S. D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.602646 · Cited by 177
How multi-organ microdevices can help foster drug development
Esch, M. B., Smith, A. S. T., Prot, J. M., Oleaga, C., Hickman, J. J., & Shuler, M. L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.003 · Cited by 165
3D in vitro models of liver fibrosis
van Grunsven, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.004 · Cited by 175
Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications
Harun‐Ur‐Rashid, M., Jahan, I., Foyez, T., & Imran, A. B. (2023) · Micromachines · doi:10.3390/mi14091786 · Cited by 185
Bioprinting Perfusion-Enabled Liver Equivalents for Advanced Organ-on-a-Chip Applications
Grix, T., Ruppelt, A., Thomas, A., Amler, A.-K., Noichl, B. P., Lauster, R., & Kloke, L. (2018) · Genes · doi:10.3390/genes9040176 · Cited by 165
“In future experiments, the printed liver organoid will be cultivated in a multi-organ-chip platform, which facilitates the in- and efflux of oxygen, carbon dioxide, nutrients and metabolites [46].”
MethodSelf-citationA Comprehensive Review of Organ-on-a-Chip Technology and Its Applications
Doost, N. F., & Srivastava, S. K. (2024) · Biosensors · doi:10.3390/bios14050225 · Cited by 184
“The study by Wagner et al. showcased the interaction of natural and drug-induced liver–testis models derived from primary adult testicular cells and liver spheroids consisting of cultured HepaRG cells and hepatic stellate cells to demonstrate the implications of multi-cell-type co-cultures [61].”
BackgroundGordon, S., Daneshian, M., Bouwstra, J., Caloni, F., Constant, S., Davies, D. E., Dandekar, G., Guzman, C. A., Fabian, E., Haltner, E., et al. (2015) · ALTEX · doi:10.14573/altex.1510051 · Cited by 158
Progress and future of in vitro models to study translocation of nanoparticles
Braakhuis, H., Kloet, S. K., Kežić, S., Kuper, C. F., Park, M. V. D. Z., Bellmann, S., van der Zande, M., Gac, S. L., Krystek, P., Peters, R., et al. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1518-5 · Cited by 149
“2013; Schimek et al. 2013; Wagner et al. 2013).”
BackgroundLee, J., Mehrotra, S., Zare‐Eelanjegh, E., Rodrigues, R. O., Akbarinejad, A., Ge, D., Amato, L., Kiaee, K., Fang, Y., Rosenkranz, A., et al. (2020) · Small · doi:10.1002/smll.202004258 · Cited by 152
Microfluidic Skin‐on‐a‐Chip Models: Toward Biomimetic Artificial Skin
Sutterby, E., Thurgood, P., Baratchi, S., Khoshmanesh, K., & Pirogova, E. (2020) · Small · doi:10.1002/smll.202002515 · Cited by 157
Tissue chips – innovative tools for drug development and disease modeling
Low, L. A., & Tagle, D. A. (2017) · Lab on a Chip · doi:10.1039/c7lc00462a · Cited by 144
Li, X., George, S. M., Vernetti, L. A., Gough, A., & Taylor, D. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00418h · Cited by 141
In vitro and ex vivo systems at the forefront of infection modeling and drug discovery
Shi, D., Mi, G., Wang, M., & Webster, T. J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.030 · Cited by 156
“In addition to single organ-on-a-chip, multi-organs-ona-chip, also known as body-on-a-chip, have been developed to understand the physiological coupling between different organs in vitro, study drug metabolism, and generate pharmacokinetic (PK) and pharmacodynamics (PD) models [214] [215] [216] [217] [218] (Fig.”
BackgroundSkin-on-a-chip models: General overview and future perspectives
Risueño, I., Valencia, L., Jorcano, J. L., & Velasco, D. (2021) · APL Bioengineering · doi:10.1063/5.0046376 · Cited by 148
Bioreactor Technologies to Support Liver Function In Vitro
Ebrahimkhani, M., Neiman, J. A. S., Raredon, M. S. B., Hughes, D., & Griffith, L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.011 · Cited by 140
“Marx and coworkers described interactions between interconnected transwell-type cultures of skin biopsies and spheroids generated from the cell line HepaRG cells combined with a stellate cell line, with the interesting observation that the skin biopsies appeared to consume albumin produced by the hepatocytes, consiste…”
Multi-Organs-on-Chips: Towards Long-Term Biomedical Investigations
Zhao, Y., Kankala, R. K., Wang, S., & Chen, A. (2019) · Molecules · doi:10.3390/molecules24040675 · Cited by 147
“Particularly, in some studies, researchers have paid more attention toward long-term cultivation and continual testing by using MOCs [12,46,129,143].”
BackgroundHuman organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 156
“To solve this problem, Marx’s group presented another scaling law, that is setting the scaled organ compartments and related parameters (size, composition, and flows) of organ chips according to the ratio of the tissue size in vivo [235].”
BackgroundMedia additives to promote spheroid circularity and compactness in hanging drop platform
Leung, B. M., Lesher‐Pérez, S. C., Matsuoka, T., Moraes, C., & Takayama, S. (2014) · Biomaterials Science · doi:10.1039/c4bm00319e · Cited by 151
Sung, J. H., Srinivasan, B., Esch, M. B., McLamb, W., Bernabini, C., Shuler, M. L., & Hickman, J. J. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214529397 · Cited by 133
“Wagner et al reported the development of a multiorgan-on-a-chip for long term cultivation of 3D human liver cells and skin tissue (73).”
Emerging trends in organ-on-a-chip systems for drug screening
Wang, Y., Gao, Y., Pan, Y., Zhou, D., Liu, Y., Yin, Y. B., Yang, J., Wang, Y., & Song, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.006 · Cited by 139
3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis
Kim, J.-Y., Fluri, D. A., Marchan, R., Boonen, K., Mohanty, S., Singh, P., Hammad, S., Landuyt, B., Hengstler, J. G., Kelm, J. M., et al. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.01.003 · Cited by 126
Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery
Ewart, L. C., Dehne, E., Fabre, K. M., Gibbs, S., Hickman, J. J., Hornberg, E., Ingelman‐Sundberg, M., Jang, K., Jones, D. R., Lauschke, V. M., et al. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052722 · Cited by 141
“The mode of pumping [external peristaltic pumps (101); on-chip micropumps (102, 103); programmable electromagnetic micropumps (104); or passive, gravity-driven flow (100, 105, 106)] and the format of the device (microtiter plate–based or proprietary design) are prominent examples.”
BackgroundSelf-citationOrgan‐on‐a‐Chip Technology for Reproducing Multiorgan Physiology
Lee, S. H., & Sung, J. H. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700419 · Cited by 130
Ud‐Din, S., & Bayat, A. (2017) · Wound Repair and Regeneration · doi:10.1111/wrr.12513 · Cited by 137
A pumpless multi‐organ‐on‐a‐chip (MOC) combined with a pharmacokinetic–pharmacodynamic (PK–PD) model
Lee, H., Kim, D. S., Ha, S. K., Choi, I., Lee, J. M., & Sung, J. H. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26087 · Cited by 130
“, 2010b), lung-liver-fat tissues (Viravaidya and Shuler, 2004), and liver-skin (Wagner et al., 2013) .”
Fernández-Checa, J. C., Bagnaninchi, P., Ye, H., Sancho‐Bru, P., Falcón‐Pérez, J. M., Royo, F., García‐Ruiz, C., Konu, Ö., Miranda, J. P., Lunov, O., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.06.021 · Cited by 141
“180 More complex multi-organ models are under development, including: i) Liver/cardiac/muscle/ neuronal system to investigate drug toxicity (doxorubicin, atorvastatin, valproic acid, APAP and N-acetyl-m-aminophenol), 181 and ii) a gut/skin/ liver/kidney system in which organ-level functions were…”
MethodAccelerating drug discovery via organs-on-chips
Chan, C. Y., Huang, P., Guo, F., Ding, X., Kapur, V., Mai, J. D., Yuen, P. K., & Huang, T. J. (2013) · Lab on a Chip · doi:10.1039/c3lc90115g · Cited by 142
Yu, F., Deng, R., Tong, W. H., Li, H., Ng, C. W., IslamBadhan, A., Iliescu, C., & Yu, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-13848-5 · Cited by 129
Schimek, K. M. S., Frentzel, S., Luettich, K., Bovard, D., Rütschle, I., Boden, L., Rambo, F., Erfurth, H., Dehne, E., Winter, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64219-6 · Cited by 157
Self-citationMicrofluidic Organ-on-a-Chip System for Disease Modeling and Drug Development
Li, Z., Hui, J., Yang, P., & Mao, H. (2022) · Biosensors · doi:10.3390/bios12060370 · Cited by 148
“The configuration of these devices may vary depending on the number of organs to be coupled [103].”
BackgroundModeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges
Sakolish, C., Esch, M. B., Hickman, J. J., Shuler, M. L., & Mahler, G. J. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.023 · Cited by 144
“The results showed that the liver chamber not only produced albumin which was subsequently consumed by the skin chamber, but equilibrium was reached with virtually no excess albumin in the system within a week of culturing (Wagner et al., 2013).”
BackgroundμOrgano: A Lego®-Like Plug & Play System for Modular Multi-Organ-Chips
Loskill, P., Marcus, S. G., Mathur, A., Reese, W. M., & Healy, K. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139587 · Cited by 125
“First, promising approaches have already been introduced in recent years, consisting of a (micro)fluidic circulation connecting cell compartments of various geometries [16,19,24].”
BackgroundEngineering and evaluating drug delivery particles in microfluidic devices
Björnmalm, M., Yan, Y., & Caruso, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.030 · Cited by 132
Chen, H. J., Miller, P. G., & Shuler, M. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00111a · Cited by 120
van den Broek, L. J., Bergers, L. L., Reijnders, C. M. A., & Gibbs, S. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9737-1 · Cited by 126
“Skin/liver-on-chip (primary) HepaRG hepatic CL, HHSCs, HDMEC Juvenile prepuce skin biopsies 28 day cultivation and 14 day repeated dose substance testing +: liver-skin cross talk demonstrated +: 14 day repeated dose testing +: endothelialized microfluidics -: usage of primary skin biopsies -: high frequency medium cha…”
Baert, Y., Rütschle, I., Cools, W., Oehme, A., Lorenz, A., Marx, U., Goossens, E., & Maschmeyer, I. (2020) · Human Reproduction · doi:10.1093/humrep/deaa057 · Cited by 126
Self-citation
Metadata
- Authors
- Wagner, I., Materne, E.-M., Brincker, S., Süßbier, U., Frädrich, C., Busek, M., Sonntag, F., Sakharov, D. A., Trushkin, E. V., Tonevitsky, A. G., Lauster, R., & Marx, U.
- Affiliations
- Technische Universität Berlin (DE)
- Fraunhofer Institute for Material and Beam Technology (DE)
- BioClinicum (Russia) (RU)
- Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
- Corresponding author
- Wagner, Ilka
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 13
- Issue
- 18
- Pages
- 3538
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2087315598
- Cited by
- 476
- References
- 20
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 32 · 2023: 29 · 2022: 38 · 2021: 33 · 2020: 40 · 2019: 36 · 2018: 56 · 2017: 54 · 2016: 46 · 2015: 38 · 2014: 34 · 2013: 9
- FWCI
- 23.37
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- DepositOnce (submittedVersion, public-domain)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Technische Universität Berlin – Universitätsbibliothek
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- multi-organ-on-a-chip, organ-on-a-chip, skin biopsy, long-term tissue culture, drug toxicity testing, troglitazone, tissue crosstalk, transwell culture, air-liquid interface, human skin
- MeSH terms
- Troglitazone, Cell Line, Cell Survival, Chromans, Humans, Liver, RNA, Skin, Biomass, Coculture Techniques, Thiazolidinediones, Microfluidic Analytical Techniques, Tissue Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.